Innoviva (INVA) FCF Payout Ratio Growth (3y) (2017 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1,215.24% |
| Mar 31, 2022 | 759.80% |
| Sep 30, 2021 | 74.12% |
| Jun 30, 2021 | 142.80% |
| Mar 31, 2021 | 592.72% |
| Dec 31, 2020 | 71.19% |
| Jun 30, 2020 | 341.73% |
| Mar 31, 2020 | 346.75% |
| Dec 31, 2019 | 270.98% |
| Jun 30, 2019 | -82.53% |
| Mar 31, 2019 | -89.83% |
| Dec 31, 2018 | 22.45% |
| Sep 30, 2018 | -85.55% |
| Jun 30, 2018 | -89.26% |
| Mar 31, 2018 | 25.99% |
| Dec 31, 2017 | 26.01% |
| Sep 30, 2017 | 87.77% |